• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

年轻患者心房颤动的导管消融:德国消融登记研究的新认识。

Catheter ablation of atrial fibrillation in the young: insights from the German Ablation Registry.

机构信息

Cardioangiologisches Centrum Bethanien Medizinische Klinik III Markus Krankenhaus, Wilhelm Epstein Str, 260431, Frankfurt am Main, Germany.

出版信息

Clin Res Cardiol. 2013 Jun;102(6):459-68. doi: 10.1007/s00392-013-0553-6. Epub 2013 Mar 17.

DOI:10.1007/s00392-013-0553-6
PMID:23503755
Abstract

INTRODUCTION

Catheter ablation of paroxysmal atrial fibrillation (PAF) has been suggested as first-line treatment for selected patients (pts). However, patient characteristics, procedural data, and complication rate in the group of young patients remain undetermined.

METHODS

The German Ablation Registry has been designed as a multi-center prospective registry. AF ablation data were collected from 51 German centers between March 2007 to September 2012 and 2 groups were defined (group A: ≤45 years, group B: >45 years). Data were analyzed according to patient characteristics, procedural data, and complications. To calculate differences between both groups CHI2 or Mann-Whitney-Wilcoxon tests was utilized.

RESULTS

A total of 7243 patients undergoing AF ablation were included (group A: 593, 8.2 %; group B: 6650, 91.8 %). Male gender and PAF were significantly more often present in group A. Patient characteristic revealed decreased co-morbidities in the young. In both groups circumferential pulmonary vein isolation represented the procedural cornerstone, whereas substrate modification was significantly more often performed in group B. Procedure-, and fluoroscopy-time was similar but there was a shorter hospital stay and a favorable complication profile in the young. After 12 months AF recurrence and use of antiarrhythmic drugs were less common in group A.

CONCLUSION

The young AF ablation patient has typically paroxysmal AF and less comorbidities. In this group, catheter ablation of AF is associated with a lower major complication rate, shorter hospitalization, and a favorable clinical outcome.

摘要

介绍

阵发性心房颤动(PAF)的导管消融已被建议作为某些患者(pts)的一线治疗方法。然而,年轻患者组的患者特征、手术数据和并发症发生率仍不确定。

方法

德国消融登记处是一个多中心前瞻性登记处。2007 年 3 月至 2012 年 9 月,从 51 个德国中心收集了 AF 消融数据,并定义了 2 个组(A 组:≤45 岁,B 组:>45 岁)。根据患者特征、手术数据和并发症对数据进行了分析。为了计算两组之间的差异,使用了 CHI2 或 Mann-Whitney-Wilcoxon 检验。

结果

共纳入 7243 例接受 AF 消融的患者(A 组:593 例,8.2%;B 组:6650 例,91.8%)。A 组中男性和 PAF 更为常见。患者特征显示年轻患者合并症减少。在两组中,环形肺静脉隔离都是手术的基石,而基质修饰在 B 组中更为常见。手术和透视时间相似,但年轻患者的住院时间较短,并发症发生率较低。在 12 个月时,A 组的 AF 复发和抗心律失常药物的使用较少。

结论

年轻的 AF 消融患者通常具有阵发性 AF 和较少的合并症。在这一组中,AF 的导管消融与较低的主要并发症发生率、较短的住院时间和良好的临床结果相关。

相似文献

1
Catheter ablation of atrial fibrillation in the young: insights from the German Ablation Registry.年轻患者心房颤动的导管消融:德国消融登记研究的新认识。
Clin Res Cardiol. 2013 Jun;102(6):459-68. doi: 10.1007/s00392-013-0553-6. Epub 2013 Mar 17.
2
Long-term symptom improvement and patient satisfaction after AV-node ablation vs. pulmonary vein isolation for symptomatic atrial fibrillation: results from the German Ablation Registry.症状性心房颤动患者行房室结消融术与肺静脉隔离术的长期症状改善和患者满意度:德国消融登记处的研究结果。
Clin Res Cardiol. 2019 Apr;108(4):395-401. doi: 10.1007/s00392-018-1368-2. Epub 2018 Sep 7.
3
Safety and efficacy of pulmonary vein isolation using a surround flow catheter with contact force measurement capabilities: A multicenter registry.使用具有接触力测量功能的环绕流导管进行肺静脉隔离的安全性和有效性:一项多中心注册研究。
J Cardiovasc Electrophysiol. 2017 Jul;28(7):762-767. doi: 10.1111/jce.13227. Epub 2017 Jun 21.
4
Cryoballoon Versus Laserballoon: Insights From the First Prospective Randomized Balloon Trial in Catheter Ablation of Atrial Fibrillation.冷冻球囊与激光球囊:导管消融治疗心房颤动的首次前瞻性随机球囊试验的新见解。
Circ Arrhythm Electrophysiol. 2021 Feb;14(2):e009294. doi: 10.1161/CIRCEP.120.009294. Epub 2021 Jan 8.
5
Safety and patient-reported outcomes in index ablation versus repeat ablation in atrial fibrillation: insights from the German Ablation Registry.在心房颤动中,首次消融与再次消融的安全性和患者报告结局:来自德国消融登记处的见解。
Clin Res Cardiol. 2021 Jun;110(6):841-850. doi: 10.1007/s00392-020-01763-1. Epub 2020 Oct 28.
6
Remote-controlled magnetic pulmonary vein isolation using a new three-dimensional non-fluoroscopic navigation system: a single-centre prospective study.使用新型三维非透视导航系统行遥控磁肺静脉隔离:单中心前瞻性研究。
Arch Cardiovasc Dis. 2013 Aug-Sep;106(8-9):423-32. doi: 10.1016/j.acvd.2013.04.008. Epub 2013 Jul 29.
7
Circumferential pulmonary vein isolation with second-generation multipolar catheter in patients with paroxysmal or persistent atrial fibrillation: Procedural and one-year follow-up results.使用第二代多极导管对阵发性或持续性心房颤动患者进行环肺静脉隔离:手术及一年随访结果
Int J Cardiol. 2017 Aug 15;241:212-217. doi: 10.1016/j.ijcard.2017.04.035. Epub 2017 Apr 12.
8
Paroxysmal and persistent atrial fibrillation ablation outcomes with the pulmonary vein ablation catheter GOLD duty-cycled phased radiofrequency ablation catheter: quality of life and 12-month efficacy results from the GOLD Atrial Fibrillation Registry.阵发性和持续性心房颤动消融的结果与肺静脉消融导管 GOLD 定频相控射频消融导管:来自 GOLD 心房颤动登记研究的生活质量和 12 个月疗效结果。
Europace. 2020 Jun 1;22(6):888-896. doi: 10.1093/europace/euaa042.
9
Safety and efficacy of pulmonary vein isolation using a circular, open-irrigated mapping and ablation catheter: A multicenter registry.使用环形、开放灌流标测和消融导管进行肺静脉隔离的安全性和有效性:一项多中心注册研究。
Heart Rhythm. 2015 Aug;12(8):1782-8. doi: 10.1016/j.hrthm.2015.05.025. Epub 2015 May 22.
10
Comparison of the Efficacy of Empiric Thoracic Vein Isolation for the Treatment of Paroxysmal and Persistent Atrial Fibrillation in Patients Without Structural Heart Disease.无结构性心脏病患者经验性胸静脉隔离治疗阵发性和持续性心房颤动的疗效比较
J Cardiovasc Electrophysiol. 2017 Mar;28(3):266-272. doi: 10.1111/jce.13159. Epub 2017 Jan 25.

引用本文的文献

1
Clinical Characteristics and Outcomes of Catheter Ablation in Young Patients With Atrial Fibrillation.年轻房颤患者导管消融的临床特征及结果
Clin Cardiol. 2025 May;48(5):e70144. doi: 10.1002/clc.70144.
2
Atrial Fibrillation Ablation in Young Adults: Measuring Quality of Life Using Patient-Reported Outcomes Over 5 Years.青年人心房颤动消融术:使用患者报告的 5 年结局指标衡量生活质量。
Circ Arrhythm Electrophysiol. 2023 Jun;16(6):e011565. doi: 10.1161/CIRCEP.122.011565. Epub 2023 May 15.
3
One-year outcomes of catheter ablation for atrial fibrillation in young patients.

本文引用的文献

1
Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): a randomized trial.射频消融与抗心律失常药物作为阵发性心房颤动(RAAFT-2)一线治疗的比较:一项随机试验。
JAMA. 2014 Feb 19;311(7):692-700. doi: 10.1001/jama.2014.467.
2
Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation.射频消融作为阵发性心房颤动的初始治疗。
N Engl J Med. 2012 Oct 25;367(17):1587-95. doi: 10.1056/NEJMoa1113566.
3
CHADS(2) and CHA(2)DS (2)-VASc score of patients with atrial fibrillation or flutter and newly detected left atrial thrombus.
年轻患者心房颤动导管消融的一年结果。
BMC Cardiovasc Disord. 2023 Feb 11;23(1):83. doi: 10.1186/s12872-022-03017-6.
4
The higher recurrence rate after catheter ablation in younger patients with atrial fibrillation suggesting different pathophysiology.年轻心房颤动患者导管消融后复发率较高提示不同的病理生理学机制。
J Interv Card Electrophysiol. 2023 Oct;66(7):1609-1619. doi: 10.1007/s10840-022-01461-0. Epub 2023 Jan 17.
5
Safety and efficacy of cryoablation for atrial fibrillation in young patients: A multicenter experience in the 1STOP project.冷冻消融治疗年轻患者心房颤动的安全性和有效性:1STOP 项目中的多中心经验。
Clin Cardiol. 2023 Feb;46(2):142-150. doi: 10.1002/clc.23951. Epub 2022 Nov 29.
6
Safety of Atrial Fibrillation Ablation in the Young - A Real World Analysis.年轻患者心房颤动消融术的安全性——一项真实世界分析
J Atr Fibrillation. 2021 Apr 30;13(6):20200489. doi: 10.4022/jafib.20200489. eCollection 2021 Apr-May.
7
Midterm results of stand-alone thoracoscopic epicardial ablation with box lesion for atrial fibrillation.单纯胸腔镜下心外膜消融“box 样”线性消融治疗心房颤动的中期结果。
Interact Cardiovasc Thorac Surg. 2021 Aug 18;33(3):354-361. doi: 10.1093/icvts/ivab148.
8
Safety and patient-reported outcomes in index ablation versus repeat ablation in atrial fibrillation: insights from the German Ablation Registry.在心房颤动中,首次消融与再次消融的安全性和患者报告结局:来自德国消融登记处的见解。
Clin Res Cardiol. 2021 Jun;110(6):841-850. doi: 10.1007/s00392-020-01763-1. Epub 2020 Oct 28.
9
Association of clinical predictors with recurrence of atrial fibrillation after catheter ablation.临床预测因素与导管消融后心房颤动复发的关系。
Ann Noninvasive Electrocardiol. 2020 Nov;25(6):e12787. doi: 10.1111/anec.12787. Epub 2020 Jul 5.
10
Clinical outcomes of catheter ablation of paroxysmal atrial fibrillation in very young population compared to older population: a prospective study.与老年人群相比,极年轻人群阵发性心房颤动导管消融的临床结局:一项前瞻性研究。
Egypt Heart J. 2019 Sep 16;71(1):11. doi: 10.1186/s43044-019-0017-z.
心房颤动或扑动伴新发左心房血栓患者的 CHADS₂ 和 CHA₂DS₂-VASc 评分。
Clin Res Cardiol. 2013 Feb;102(2):139-44. doi: 10.1007/s00392-012-0507-4. Epub 2012 Sep 15.
4
2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society.2012年心房颤动导管消融与外科消融专家共识声明:患者选择、手术技术、患者管理与随访、定义、终点及研究试验设计的建议:心律学会(HRS)心房颤动导管消融与外科消融特别工作组报告。与欧洲心脏病学会(ESC)注册分支欧洲心律协会(EHRA)及欧洲心脏心律失常学会(ECAS)合作制定;并与美国心脏病学会(ACC)、美国心脏协会(AHA)、亚太心律学会(APHRS)和胸外科医师学会(STS)协作。得到美国心脏病学会基金会、美国心脏协会、欧洲心脏心律失常学会、欧洲心律协会、胸外科医师学会、亚太心律学会和心律学会管理机构的认可。
Heart Rhythm. 2012 Apr;9(4):632-696.e21. doi: 10.1016/j.hrthm.2011.12.016. Epub 2012 Mar 1.
5
Radiofrequency catheter ablation and antiarrhythmic drug therapy: a prospective, randomized, 4-year follow-up trial: the APAF study.射频导管消融与抗心律失常药物治疗:一项前瞻性、随机、4 年随访试验:APA 研究。
Circ Arrhythm Electrophysiol. 2011 Dec;4(6):808-14. doi: 10.1161/CIRCEP.111.966408. Epub 2011 Sep 23.
6
Isolating the pulmonary veins as first-line therapy in patients with lone paroxysmal atrial fibrillation using the cryoballoon.使用冷冻球囊对孤立性阵发性心房颤动患者行肺静脉隔离作为一线治疗。
Europace. 2012 Feb;14(2):197-203. doi: 10.1093/europace/eur299. Epub 2011 Sep 20.
7
Prospective assessment of short- and long-term quality of life after ablation for atrial fibrillation.前瞻性评估心房颤动消融术后的短期和长期生活质量。
J Cardiovasc Electrophysiol. 2012 Feb;23(2):121-7. doi: 10.1111/j.1540-8167.2011.02165.x. Epub 2011 Sep 13.
8
Anticoagulant therapy and risk of cerebrovascular events after catheter ablation of atrial fibrillation in the elderly.老年患者行导管消融心房颤动后抗凝治疗与脑血管事件风险
J Cardiovasc Electrophysiol. 2012 Jan;23(1):36-43. doi: 10.1111/j.1540-8167.2011.02141.x. Epub 2011 Aug 1.
9
Complications arising from catheter ablation of atrial fibrillation: temporal trends and predictors.房颤导管消融术相关并发症:时间趋势与预测因素。
Heart Rhythm. 2011 Dec;8(12):1869-74. doi: 10.1016/j.hrthm.2011.07.025. Epub 2011 Jul 26.
10
Real-life observations of clinical outcomes with rhythm- and rate-control therapies for atrial fibrillation RECORDAF (Registry on Cardiac Rhythm Disorders Assessing the Control of Atrial Fibrillation).房颤节律和心率控制治疗的临床结局的真实世界观察 RECORDAF(心律失常和评估房颤控制的心脏节律障碍登记处)。
J Am Coll Cardiol. 2011 Jul 26;58(5):493-501. doi: 10.1016/j.jacc.2011.03.034.